Choi, Elliot H.
Suh, Susie http://orcid.org/0000-0002-4921-1429
Foik, Andrzej T. http://orcid.org/0000-0003-1110-9223
Leinonen, Henri
Newby, Gregory A.
Gao, Xin D.
Banskota, Samagya
Hoang, Thanh
Du, Samuel W. http://orcid.org/0000-0002-9655-3659
Dong, Zhiqian
Raguram, Aditya
Kohli, Sajeev
Blackshaw, Seth
Lyon, David C.
Liu, David R. http://orcid.org/0000-0002-9943-7557
Palczewski, Krzysztof http://orcid.org/0000-0002-0788-545X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM008803, T32GM007250, F30EY029136, T32GM007250, T32EY024236, T32GM008620, U01AI142756, R35GM118062)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (UG3AI150551)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (UG3AI150551)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1HG009490)
U.S. Department of Health & Human Services | NIH | National Eye Institute (R01EY009339, R24EY027283)
U.S. Department of Health & Human Services | NIH | National Eye Institute
Research to Prevent Blindness (SIA)
Article History
Received: 5 July 2021
Accepted: 17 March 2022
First Online: 5 April 2022
Competing interests
: K.P. is the Chief Scientific Officer of Polgenix Inc. D.R.L. is a consultant and equity owner of Beam Therapeutics, Prime Medicine, and Pairwise Plants, companies that use genome editing. The Broad Institute has filed patent applications on base editing. The remaining authors declare no competing interests.